WhiteLab Genomics
Paris
About WhiteLab Genomics
WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload and vector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.5M
- Funding stage: Seed
- Last round: Seed (Sep 2022)
- Website: whitelabgx.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/whitelab-genomics-87031 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.